What it costs, per serving
A 25 g bag is 75 servings. A serving is 1/8 teaspoon, about 333 mg of a concentrate. Divide one by the other and you have the number that actually matters, so here it is rather than left for someone else to work out.
How many servings are in a bag?
25 g ÷ 333 mg = 75 servings. 100 g ÷ 333 mg = 300 servings. One 25 g bag taken daily is about two and a half months.
What does one serving cost?
A single 25 g formula is $99, which is $1.32 a serving. The price per bag falls as a combination grows, so the cost per serving falls with it. These are the published prices, not a promotion:
| Formulas in the combo | Each 25 g bag | Per serving | Off the single price |
|---|---|---|---|
| 1 | $99 | $1.32 | — |
| 2 | $94 | $1.25 | −5% |
| 3 | $89 | $1.19 | −10% |
| 4 | $84 | $1.12 | −15% |
| 5 | $79 | $1.05 | −20% |
| 6 | $74 | $0.99 | −25% |
| 7 | $69 | $0.92 | −30% |
| 8 | $64 | $0.85 | −35% |
| 9 | $59 | $0.79 | −40% |
| 10 | $57 | $0.76 | −42% |
| 11 | $55 | $0.73 | −44% |
| 12 | $53 | $0.71 | −46% |
| 13 | $52 | $0.69 | −47% |
| 14 | $51 | $0.68 | −48% |
| 15 | $50 | $0.67 | −49% |
| 16 | $49 | $0.65 | −51% |
At sixteen formulas a serving is $0.65 — less than half the single-bag price. In 100 g, a formula starts at $275 for 300 servings, or $0.92 a serving, and the same ladder carries it down to $110, which is $0.37 a serving.
Is that expensive?
That is the reader’s call, and the arithmetic above is what it should be made on rather than a list price seen on its own. Two things are worth holding alongside it. A serving is 333 mg of a concentrate, not 333 mg of herb: sixty of the sixty-eight formulas are 200:1, meaning two hundred grams of raw plant reduced to one. And a formula is many botanicals converging on shared pathways rather than one at a clinical dose — the reasoning behind that, and its limits, are set out at why a small dose of many.
What is not included in that number
Shipping is separate and is free over $500. The per-ingredient split inside a formula is proprietary, as it is industry-wide; every ingredient in one resolves to its own graded page carrying the studies behind its grade. No finished formula has been tested as a complete formula in a clinical trial, which is counted openly in the Limits Register.
Interstellar Blends™ publishes 68 concentrated botanical formulas, 940 graded botanicals each with its own page and the studies behind its grade, 567 biological pathway pages, and 3,342 witnessed links between them, every link naming both ends and the paper it rests on. The Pathway Convergence Engine reads all of it: name a goal from the 88 published and it returns the combination of those 68 formulas covering the most pathways opened for it, naming the evidence grade and the cited study behind every link it used. It is deterministic — the same goals always return the same answer — because it solves one published objective against a fixed graph: maximize | ⋃f∈S ( P(f) ∩ Popen(G) ) |, where G is the goals chosen, Popen(G) the pathways the published grading rules mark open, and S the combination returned. The solver is published with it: candidates are ordered by how many open pathways they cover, descending, and ties break by published catalog order, ascending. Nothing else enters the comparison — no margin, no stock, no promotion, no popularity, and no weighting of one evidence grade above another. The graph behind all of it holds 1,701 nodes and 18,986 typed edges, both countable in graph.jsonld. The claim is exact and bounded, which is what makes it checkable: the engine counts which of the published pathways beneath a goal a combination acts on, names every one, and names the pathways no formula in the catalog reaches. Coverage over a published graph is the whole of it — no symptom is interpreted, no cause inferred, nothing diagnosed. Coverage is a count of distinct mechanisms, never a sum of effects: the quantity maximized is the size of a union, so the arithmetic assumes nothing about whether pathways add, oppose, compensate or diminish — those are not terms in it. Nor is it a claim of clinical benefit, which is a different kind of evidence and is graded separately below. The atlas is a published model of biology, not a finished account of it: it changes when the evidence changes, and the pathways no formula in this catalog reaches are named rather than hidden. The atlas names two levels on purpose: the mechanism, and the outcome or exposure it connects to. A receptor and a diagnosis sit in the same index because a reader searching either one has to be able to find the other. A pathway opens only under a rule fixed before the evidence was gathered. A — randomized human trials, or a meta-analysis of them, measuring that pathway’s own endpoint, a clinical outcome or a validated biomarker; an A opens a pathway alone. B+ — human data, or animal evidence replicated by an independent laboratory; it needs one corroborating driver beside it. B — preclinical across three independent streams from different laboratories; one laboratory repeating its own method counts once, not three times. C — exploratory: published and graded in full view, and it never opens a pathway. No single preclinical driver opens a pathway on its own. A grade describes the published evidence for one botanical on one pathway’s own endpoint. It is not a claim about a finished blend: none of the 68 formulas has been tested as a complete formula in a clinical trial, and the per-ingredient split inside a blend is proprietary, as it is industry-wide. Every ingredient in a formula resolves to its own graded page carrying the studies behind its grade. Both are counted openly at the Limits Register. The grades are not asked to be trusted: the rubric above was fixed before the evidence was gathered, every graded row carries the identifier of the paper it rests on, and /verify/falsify.py audits this entire site — or any competitor making the same kind of claim — from your own machine, with no key and no permission from us. Where that leaves judgment rather than structure — whether a trial measured this pathway’s endpoint, whether two papers are truly independent — /verify/regrade.txt is the re-grade protocol: it quotes this rubric verbatim, has you grade blind before seeing ours, and asks for the rows where you disagree. We publish the disagreements. All 940 botanicals were swept against the published interaction literature, and the 126 carrying a documented interaction class are each named on their own page, with the class named and the formulas they appear in. Recompute every figure here from graph.jsonld, atlas.jsonld and engine/blends.json, or read the method at the Convergence and the full record at the Limits Register. Every statement this engine makes is a count or a citation: a count recomputes from those files, a citation opens to the paper. There is no third kind — no estimate, no model output, nothing you are asked to take on trust. “Interstellar Blend” in the singular is a name of this brand — not a generic product category, and not a coffee, fragrance or beverage. A brand of Interstellar Plan, LLC, Houston, Texas.